Experience with an adverse drug reaction reporting program in a neurology specialty clinic

OBJECTIVE: To describe an adverse drug reaction (ADR) reporting program that was developed in a university-affiliated neurology specialty clinic. METHODS: Reportable ADRs were identified through 3 mechanisms: by clinicians through routine visits, by patients who were encouraged to follow up with the pharmacist in the clinic, and by the pharmacist who contacted high-risk patients. Patient demographics, the suspected drug(s), elements to define probability, and outcomes were documented, collated, and analyzed for trends and opportunities for continuous quality-improvement efforts. Information was shared with clinic administrators and clinicians. Serious ADRs were reported to the Food and Drug Administration. RESULTS: The experience during a 1-year period, during which 40 ADRs were reported, is described. Medications by frequency of report and types of reactions are reported. None of the ADRs required admission to the hospital. Pharmacy personnel reported the majority of ADRs (92.5%). CONCLUSIONS: This program is successfully incorporated within daily practice and is an integral part of quality-improvement efforts.